Male Breast Cancer Completed Phase 1 Trials for Pertuzumab (DB06366)
Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028546 (Male Breast Cancer) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | Treatment |